Pharmaceutical Services (Amendment) Regulations (Northern Ireland) 2009

Contents

1Citation, commencement and interpretation#

(1)These Regulations may be cited as the Pharmaceutical Services (Amendment) Regulations (Northern Ireland) 2009 and shall come into operation on 5th October 2009.

(2)In these Regulations “the Pharmaceutical Regulations” means the Pharmaceutical Services Regulations (Northern Ireland) 1997.

2Amendment of regulation 2 of the Pharmaceutical Regulations#

(1)Regulation 2 of the Pharmaceutical Regulations (interpretation) is amended as follows.

(2)After “the 1997 Order” insert:“• “APMS” means Alternative Provider Medical Services arrangements made under Article 56(2)(b) of the Order (primary medical services) for the provision of primary medical services and “APMS contractor” shall be construed accordingly;”

(3)After “the Prescription of Drugs Regulations” insert:“• “RBMS” means a Regional Board Medical Services provider under Article 56(2)(a) of the Order (primary medical services) for the provision of primary medical services and “RBMS practice” shall be construed accordingly;”

(4)After paragraph (3) insert the following paragraphs—“4 In these Regulations, “emergency requiring the flexible provision of pharmaceutical services” means an emergency declared by means of a direction to the Regional Board under section 6 of the 2009 Act to the effect that, as a result of the threatened damage to human welfare caused or which may be caused by the illness designated in the direction, the Regional Board must for a specified period—a exercise, orb where a discretion is conferred, consider exercising,one or more of their functions under regulation 6A, 12(7A) or paragraph 4A of Schedule 2 subject to any conditions or limitations set out in the direction.5 Where—a a direction of the type mentioned in paragraph (4) is given; andb the Department issues a further direction changing the specified period of the emergency,the duration of the emergency is to be construed in accordance with the specified period as so changed.”

3New regulation 6A of the Pharmaceutical Regulations#

After regulation 6, insert the following regulation—“6A 1 Regulations 6(2)(b), 6(4) and (4A) shall not apply to an application for a temporary amendment to the pharmaceutical list which the Regional Board is satisfied is necessary or desirable because of an emergency requiring the flexible provision of pharmaceutical services.2 In the circumstances described in paragraph (1), the Regional Board may make a temporary amendment to an entry in the pharmaceutical list, but—a only for a specified period (which shall not be longer than the period of the emergency specified in the direction given by the Department) which the Regional Board may extend or curtail in appropriate circumstances; andb the applicant may revert to the applicant’s overridden entry in the pharmaceutical list before the end of the period specified by the Regional Board, on giving the Regional Board at least 24 hours notice.3 There is no right of appeal under these Regulations in respect of a decision to make or not to make, or to curtail the duration of, a temporary amendment to a pharmaceutical list made under this regulation.”

4Amendment of regulation 12 of the Pharmaceutical Regulations#

In regulation 12 (arrangements for the provision of pharmaceutical services by doctors), after paragraph (7) insert the following paragraphs—“7A Notwithstanding the preceding provisions of this regulation, the Regional Board may also require a doctor who already provides pharmaceutical services to patients on a relevant patient list to provide pharmaceutical services to patients who are not on that list (“temporary services”)—a during an emergency requiring the flexible provision of pharmaceutical services;b where, as a result of the temporary closure of premises from which medicines, drugs or appliances are normally dispensed, the Regional Board considers that, in order to secure continuing adequate provision of pharmaceutical services during the emergency, it is necessary for it to require provision of those temporary services; andc for a specified period (which shall not be longer than the period of the emergency specified in the direction given by the Department) which the Regional Board may extend or curtail in appropriate circumstances.7B Where a doctor is required to provide temporary services by virtue of paragraph (7A), any services provided to a patient as a result of that requirement are to be treated as services provided as part of the arrangements under which the doctor provides primary medical services to patients on the relevant patient list.7C There is no right of appeal under these Regulations in respect of a decision—a to require, or not to require, a doctor to provide temporary services; orb to extend or curtail the duration of any requirement imposed by virtue of paragraph (7A),but the requirement must be curtailed if the doctor notifies the Regional Board in writing that the doctor is unwilling to provide pharmaceutical services to patients who are not on the relevant patient list during the emergency (and so wishes to revert to the doctor’s overridden arrangements for the provision of pharmaceutical services).7D Nothing in paragraph (7A) shall be taken as requiring a doctor (or a GMS, APMS contractor or RBMS practice) to provide pharmaceutical services to patients at times when, or from premises at which, the doctor (or contractor or practice) is not also providing pharmaceutical services to patients on a relevant patient list.”

5New Regulation 13A of the Pharmaceutical Regulations#

After regulation 13, insert the following regulation—“13A Where, during an emergency requiring the flexible provision of pharmaceutical services, arrangements for the provision of pharmaceutical services are overridden by temporary arrangements—a any proceedings with regard to the overridden arrangements are unaffected by that overriding (although they may need to be stayed during the emergency for other reasons); andb if as a result of those proceedings, the overridden arrangements require amendment before the end of the temporary arrangements, when the emergency ends, the reversion to the overridden arrangements shall be to the overridden arrangements as amended as a result of those proceedings.”

6New paragraph 4A of Schedule 2 to the Pharmaceutical Regulations#

After paragraph 4 of Schedule 2, insert the following paragraph—“4A 1 Notwithstanding the provisions of this Part, during an emergency requiring the flexible provision of pharmaceutical services, the Regional Board may, on application from a pharmacist (“P”), permit P a temporary change to the days on which or times at which P is obliged to provide pharmaceutical services at the premises from which P has undertaken to provide pharmaceutical services, or permit temporary closure of those premises, if—a P gives at least 24 hours notice of the change or closure; andb the reasons given by P for the request are, in the opinion of the Regional Board adequate reasons.2 The Regional Board need not approve the request in advance of the change or closure, and if it does not do so but decides subsequently that P’s reasons are not, in its opinion, adequate reasons, then the days on which or times at which P is obliged to provide pharmaceutical services at the premises are to revert to the overridden days or times, from the day after the date on which that decision is given to P.”

7Amendment of paragraph 16 of Schedule 2 to the Pharmaceutical Regulations#

In paragraph 16 of Schedule 2 (terms of service for doctors who provide pharmaceutical services– fees and charges), for sub-paragraph (2) substitute the following sub-paragraph—“2 Where a doctor who provides pharmaceutical services provides a drug, appliance or additional service as part of the terms of service of a doctor providing pharmaceutical services, if—a a GMS contractor had provided that drug, appliance or service under a GMS contract, the contractor would have been entitled to a payment for that drug, appliance or service by virtue of directions under Article 57C of the 1972 Order; andb the drug, appliance or service has been provided in accordance with the terms of service of the doctor providing pharmaceutical services (even if, by virtue of conditions imposed by the GMS Regulations, a GMS contractor could not have had equivalent terms of service),the Regional Board shall credit the doctor providing pharmaceutical services with that payment.”

Contains public sector information licensed under the Open Government Licence v3.0.